| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |